BACKGROUND: Late effects of treatment in children diagnosed and treated for brain tumours in infancy is a major concern. Assessment of infants presenting with brain tumours is difficult and there is little information available regarding the development of infants prior to treatment and hence the impact of the tumour itself on developmental outcomes. AIM: To describe the development of children diagnosed with brain tumours in infancy and to document their cognitive and adaptive function at school entry. METHOD: Infants were psychologically evaluated at the time of diagnosis of a brain tumour and during their fifth or sixth year in preparation for school entry. RESULTS: Children diagnosed with brain tumours in infancy display developmental delays in a number of areas of adaptive function. By the time these children are school age they display further compromise in cognitive and academic skills and adaptive behaviour. Higher levels of deficit at follow-up were associated with tumour location in the supratentorium, younger age at diagnosis and longer time since diagnosis. The effect of radiotherapy could not be determined because of differing degrees of developmental compromise in the treatment groups at baseline. CONCLUSION: Brain tumours in infancy confer a risk of poor developmental progress at the time of diagnosis. These children display additional compromise of development by the time they reach school age. Research protocols evaluating the impact of treatment in infants diagnosed with brain tumours need to take account of the developmental status of the child at diagnosis.
BACKGROUND: Late effects of treatment in children diagnosed and treated for brain tumours in infancy is a major concern. Assessment of infants presenting with brain tumours is difficult and there is little information available regarding the development of infants prior to treatment and hence the impact of the tumour itself on developmental outcomes. AIM: To describe the development of children diagnosed with brain tumours in infancy and to document their cognitive and adaptive function at school entry. METHOD:Infants were psychologically evaluated at the time of diagnosis of a brain tumour and during their fifth or sixth year in preparation for school entry. RESULTS:Children diagnosed with brain tumours in infancy display developmental delays in a number of areas of adaptive function. By the time these children are school age they display further compromise in cognitive and academic skills and adaptive behaviour. Higher levels of deficit at follow-up were associated with tumour location in the supratentorium, younger age at diagnosis and longer time since diagnosis. The effect of radiotherapy could not be determined because of differing degrees of developmental compromise in the treatment groups at baseline. CONCLUSION:Brain tumours in infancy confer a risk of poor developmental progress at the time of diagnosis. These children display additional compromise of development by the time they reach school age. Research protocols evaluating the impact of treatment in infants diagnosed with brain tumours need to take account of the developmental status of the child at diagnosis.
Authors: A W Walter; R K Mulhern; A Gajjar; R L Heideman; D Reardon; R A Sanford; X Xiong; L E Kun Journal: J Clin Oncol Date: 1999-12 Impact factor: 44.544
Authors: E Hoppe-Hirsch; L Brunet; F Laroussinie; G Cinalli; A Pierre-Kahn; D Rénier; C Sainte-Rose; J F Hirsch Journal: Childs Nerv Syst Date: 1995-06 Impact factor: 1.475
Authors: Alexandra K Roth; M Douglas Ris; Jessica Orobio; Judy Xue; Anita Mahajan; Arnold C Paulino; David Grosshans; M Fatih Okcu; Murali Chintagumpala; Lisa S Kahalley Journal: Pediatr Blood Cancer Date: 2019-11-17 Impact factor: 3.167
Authors: Jason M Ashford; Kelli L Netson; Kellie N Clark; Thomas E Merchant; Victor M Santana; Shengjie Wu; Heather M Conklin Journal: J Neurooncol Date: 2014-05 Impact factor: 4.130
Authors: Naveen Mehrotra; Mohammed F Shamji; Michael Vassilyadi; Enrique C G Ventureyra Journal: Childs Nerv Syst Date: 2009-06-24 Impact factor: 1.475
Authors: Jeanelle S Ali; Jason M Ashford; Michelle A Swain; Lana L Harder; Bonnie L Carlson-Green; Jonathan M Miller; Joanna Wallace; Ryan J Kaner; Catherine A Billups; Arzu Onar-Thomas; Thomas E Merchant; Amar Gajjar; Heather M Conklin Journal: J Clin Oncol Date: 2021-05-04 Impact factor: 50.717
Authors: Marieke Anna de Ruiter; Antoinette Yvonne Narda Schouten-van Meeteren; Dannis Gilbert van Vuurden; Heleen Maurice-Stam; Corrie Gidding; Laura Rachel Beek; Bernd Granzen; Jaap Oosterlaan; Martha Alexandra Grootenhuis Journal: Qual Life Res Date: 2015-08-20 Impact factor: 4.147